-transparent.png){kind=logo}
Serum thyroxine, thyrotrophin, and thyroid microsomal antibody levels were measured in 20 patients with Hashimoto's thyroiditis and hypothyroidism before, during, and after treatment with carbimazole or placebo. Thyroid microsomal antibody levels fell during treatment in the 10 patients who received carbimazole, while serum thyroxine and thyrotrophin levels did not change. There were no changes in the placebo group. The study proves support for the concept that carbimazole may act directly on autoantibody synthesising lymphocytes localised in the thyroid. Such an effect might be valuable in influencing the autoimmune process in autoimmune thyroid disease.
Related Publications
A M McGregor, and
H K Ibbertson, and
B R Smith, and
R Hall
March 1984,
Lancet (London, England),
A M McGregor, and
H K Ibbertson, and
B R Smith, and
R Hall
March 2007,
Expert review of clinical immunology,
A M McGregor, and
H K Ibbertson, and
B R Smith, and
R Hall
January 1985,
British medical journal (Clinical research ed.),
A M McGregor, and
H K Ibbertson, and
B R Smith, and
R Hall
August 1987,
Clinical and experimental immunology,
A M McGregor, and
H K Ibbertson, and
B R Smith, and
R Hall
January 1986,
Annales d'endocrinologie,
A M McGregor, and
H K Ibbertson, and
B R Smith, and
R Hall
November 2016,
Autoimmunity,
A M McGregor, and
H K Ibbertson, and
B R Smith, and
R Hall
October 1993,
The Journal of clinical endocrinology and metabolism,
A M McGregor, and
H K Ibbertson, and
B R Smith, and
R Hall
December 1988,
Clinica chimica acta; international journal of clinical chemistry,
A M McGregor, and
H K Ibbertson, and
B R Smith, and
R Hall
June 1963,
Minerva chirurgica,
A M McGregor, and
H K Ibbertson, and
B R Smith, and
R Hall
July 1968,
Revista clinica espanola,
